Fresenius Kabi announced that Arunesh Verma joined as the president of Fresenius Kabi USA and as a member of its global executive leadership team. As a member of the executive leadership team, Verma reports to CEO Pierluigi Antonelli. He holds responsibility for the commercial operations of Fresenius Kabi in the U.S., succeeding John Ducker. Ducker […]
Personnel
Tandem Diabetes Care has a new COO
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it appointed Jean-Claude “JC” Kyrillos as its new EVP and COO. Kyrillos’ appointment goes into effect on June 21, 2024. He joins Tandem with more than 20 years of experience in global executive leadership across medtech, digital health and healthcare management. Most recently, Kyrillos served in operating company […]
Medtronic Diabetes has a new medical affairs director
Medtronic (NYSE:MDT) announced today that Dr. Goran Petrovski joined its Diabetes operating unit as medical affairs director. His role includes shaping the clinical evidence strategy and product design for Medtronic’s diabetes technology. The company also expects him to strengthen its presence in Central Europe, the Middle East and Africa. Petrovski brings more than 20 years […]
Stevanato Group brings former CEO back to corner office
Stevanato Group (NYSE:STVN) announced today that its board of directors appointed Franco Stevanato as its new CEO. Stevanato, currently a board director and the company’s executive chair, succeeds Franco Moro in the corner office. Moro’s employment agreement continues through June 30, 2024, after which he will remain on the company’s board. This marks Stevanato’s second […]
Vaccine patch maker Vaxess raises $12M, names new CEO
Shelf-stable vaccine patch maker Vaxess Technologies announced today that it raised $12 million and appointed Rachel Sha as its new CEO. This round brings the company’s total funding to more than $90 million after it raised $9 million last September as well. Investors included RA Capital Management, Engine Ventures, GHIC and Mission Bio Capital. Cambridge, […]
Kindeva Drug Delivery has a new COO
Kindeva Drug Delivery announced today that it appointed Denis Johnson as its new chief operating officer (COO). Johnson’s responsibilities include leading global operations for Kindeva’s manufacturing and R&D facilities across the U.S. and UK. The company expects him to facilitate the expansion and opening of the company’s new aseptic injectable fill-finish site in Bridgeton, Missouri. […]
Insulet picks new CFO following McMillan’s move to 3M spinoff
Insulet (Nasdaq:PODD) announced today that it appointed Ana Maria Chadwick as its new EVP, CFO and treasurer. Chadwick’s appointment — which goes into effect on April 22, 2024 — follows an extensive search process conducted by Insulet. That search spanned nearly six months after former CFO Wayde McMillan left for 3M’s Solventum healthcare spinoff in […]
Narcan nasal spray maker Emergent BioSolutions has a new CEO
Emergent BioSolutions (NSYE:EBS) announced today that it appointed Joseph C. Papa as its new president and CEO. Papa’s appointment to the corner office of the Gaithersburg, Maryland-based company went into effect today. He succeeds Haywood Miller, who stepped down from his role as interim CEO today as well. Emergent BioSolutions is known for its Narcan […]
Enable Injections promotes COO from within
Wearable drug delivery technology maker Enable Injections announced today that it named David Kroekel as its new COO. Cincinnati-based Enable develops the enFuse platform, whichallows hands-free, hidden needle drug delivery of up to 25 mL. Its simple design enables flexibility for at-home self-administration or in-clinic use. The FDA cleared the system for the delivery of […]
Former Tandem CCO joins Ascensia as president of CGM
Ascensia Diabetes Care parent company PHC Holdings and Senseonics announced today that Ascensia named Brian Hansen its president of CGM. Hansen’s appointment to the newly created role at the global distributor of Senseonics’ Eversense CGM went into effect today, Feb. 6. Responsibilities for Hansen include the global commercialization and growth of the Eversense system. The fully […]
